Literature DB >> 20070308

Secreted cysteine proteases of the carcinogenic liver fluke, Opisthorchis viverrini: regulation of cathepsin F activation by autocatalysis and trans-processing by cathepsin B.

Jittiyawadee Sripa1, Thewarach Laha, Joyce To, Paul J Brindley, Banchob Sripa, Sasithorn Kaewkes, John P Dalton, Mark W Robinson.   

Abstract

Opisthorchis viverrini is an important helminth pathogen of humans that is endemic in Thailand and Laos. Adult flukes reside within host bile ducts and feed on epithelial tissue and blood cells. Chronic opisthorchiasis is associated with severe hepatobiliary diseases such as cholangiocarcinoma. Here we report that adult O. viverrini secrete two major cysteine proteases: cathepsin F (Ov-CF-1) and cathepsin B1 (Ov-CB-1). Ov-CF-1 is secreted as an inactive zymogen that autocatalytically processes and activates to a mature enzyme at pH 4.5 via an intermolecular cleavage at the prosegment-mature domain junction. Ov-CB-1 is also secreted as a zymogen but, in contrast to Ov-CF-1, is fully active against peptide and macromolecular substrates despite retaining the N-terminal prosegment. The active Ov-CB-1 zymogen was capable of trans-activating Ov-CF-1 by proteolytic removal of its prosegment at pH 5.5, a pH at which the Ov-CF-1 zymogen cannot autocatalytically activate. Both cathepsins hydrolyse human haemoglobin but their combined action more efficiently degrades haemoglobin to smaller peptides than each enzyme alone. Ov-CF-1 degraded extracellular matrix proteins more effectively than Ov-CB-1 at physiological pH. We propose that Ov-CB-1 regulates Ov-CF-1 activity and that both enzymes work together to degrade host tissue contributing to the development of liver fluke-associated cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20070308      PMCID: PMC2888773          DOI: 10.1111/j.1462-5822.2010.01433.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  54 in total

Review 1.  Opisthorchiasis control in Thailand.

Authors:  P Jongsuksuntigul; T Imsomboon
Journal:  Acta Trop       Date:  2003-11       Impact factor: 3.112

2.  Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion.

Authors:  M Cygler; J Sivaraman; P Grochulski; R Coulombe; A C Storer; J S Mort
Journal:  Structure       Date:  1996-04-15       Impact factor: 5.006

3.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

4.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

5.  Autocatalytic processing of procathepsin B is triggered by proenzyme activity.

Authors:  Jerica Rozman Pungercar; Dejan Caglic; Mohammed Sajid; Marko Dolinar; Olga Vasiljeva; Urska Pozgan; Dusan Turk; Matthew Bogyo; Vito Turk; Boris Turk
Journal:  FEBS J       Date:  2009-02       Impact factor: 5.542

6.  Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificity.

Authors:  Sutas Suttiprapa; Jason Mulvenna; Ngo Thi Huong; Mark S Pearson; Paul J Brindley; Thewarach Laha; Sopit Wongkham; Sasithorn Kaewkes; Banchob Sripa; Alex Loukas
Journal:  Int J Biochem Cell Biol       Date:  2008-10-19       Impact factor: 5.085

Review 7.  Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.

Authors:  John P Dalton; Sandra O Neill; Colin Stack; Peter Collins; Alan Walshe; Mary Sekiya; Sean Doyle; Grace Mulcahy; Deborah Hoyle; Eric Khaznadji; Nathalie Moiré; Gerard Brennan; Angela Mousley; Natalia Kreshchenko; Aaron G Maule; Sheila M Donnelly
Journal:  Int J Parasitol       Date:  2003-09-30       Impact factor: 3.981

Review 8.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

9.  Expression of an active cathepsin B-like protein Sm31 from Schistosoma mansoni in insect cells.

Authors:  B Götz; R Felleisen; E Shaw; M Q Klinkert
Journal:  Trop Med Parasitol       Date:  1992-12

10.  Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverrini.

Authors:  Thewarach Laha; Porntip Pinlaor; Jason Mulvenna; Banchob Sripa; Manop Sripa; Michael J Smout; Robin B Gasser; Paul J Brindley; Alex Loukas
Journal:  BMC Genomics       Date:  2007-06-22       Impact factor: 3.969

View more
  15 in total

1.  Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni.

Authors:  Adéla Jílková; Pavlína Rezácová; Martin Lepsík; Martin Horn; Jana Váchová; Jindrich Fanfrlík; Jirí Brynda; James H McKerrow; Conor R Caffrey; Michael Mares
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

Review 2.  Infection with the carcinogenic human liver fluke, Opisthorchis viverrini.

Authors:  Michael J Smout; Banchob Sripa; Thewarach Laha; Jason Mulvenna; Robin B Gasser; Neil D Young; Jeffrey M Bethony; Paul J Brindley; Alex Loukas
Journal:  Mol Biosyst       Date:  2011-02-11

3.  Characterization of the secreted cathepsin B cysteine proteases family of the carcinogenic liver fluke Clonorchis sinensis.

Authors:  Wenjun Chen; Xiaoyun Wang; Xiaoli Lv; Yanli Tian; Yanquan Xu; Qiang Mao; Mei Shang; Xuerong Li; Yan Huang; Xinbing Yu
Journal:  Parasitol Res       Date:  2014-07-03       Impact factor: 2.289

4.  Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans.

Authors:  Sujit S Nair; Anitha Bommana; Suresh B Pakala; Kazufumi Ohshiro; Amanda J Lyon; Sutas Suttiprapa; Maria V Periago; Thewarach Laha; Peter J Hotez; Jeffrey M Bethony; Banchob Sripa; Paul J Brindley; Rakesh Kumar
Journal:  Hepatology       Date:  2011-09-06       Impact factor: 17.425

5.  RNA interference targeting cathepsin B of the carcinogenic liver fluke, Opisthorchis viverrini.

Authors:  Jittiyawadee Sripa; Porntip Pinlaor; Paul J Brindley; Banchob Sripa; Sasithorn Kaewkes; Mark W Robinson; Neil D Young; Robin B Gasser; Alex Loukas; Thewarach Laha
Journal:  Parasitol Int       Date:  2011-05-01       Impact factor: 2.230

6.  Evaluation of liver fluke recombinant cathepsin B-1 protease as a serodiagnostic antigen for human opisthorchiasis.

Authors:  Jittiyawadee Sripa; Paul J Brindley; Banchob Sripa; Alex Loukas; Sasithorn Kaewkes; Thewarach Laha
Journal:  Parasitol Int       Date:  2011-06-17       Impact factor: 2.230

7.  Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepatica.

Authors:  Mark W Robinson; Ileana Corvo; Peter M Jones; Anthony M George; Matthew P Padula; Joyce To; Martin Cancela; Gabriel Rinaldi; Jose F Tort; Leda Roche; John P Dalton
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

8.  Adaptive Radiation of the Flukes of the Family Fasciolidae Inferred from Genome-Wide Comparisons of Key Species.

Authors:  Young-Jun Choi; Santiago Fontenla; Peter U Fischer; Thanh Hoa Le; Alicia Costábile; David Blair; Paul J Brindley; Jose F Tort; Miguel M Cabada; Makedonka Mitreva
Journal:  Mol Biol Evol       Date:  2020-01-01       Impact factor: 16.240

Review 9.  The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer.

Authors:  Banchob Sripa; Paul J Brindley; Jason Mulvenna; Thewarach Laha; Michael J Smout; Eimorn Mairiang; Jeffrey M Bethony; Alex Loukas
Journal:  Trends Parasitol       Date:  2012-09-01

10.  Molecular changes in Opisthorchis viverrini (Southeast Asian liver fluke) during the transition from the juvenile to the adult stage.

Authors:  Aaron R Jex; Neil D Young; Jittiyawadee Sripa; Ross S Hall; Jean-Pierre Scheerlinck; Thewarach Laha; Banchob Sripa; Robin B Gasser
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.